Trial Details
COMPLETEDBasic Information
| Clinical ID | c3432 |
|---|---|
| Identifier | NCT02073526 |
| Trial Title | Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: Infliximab, adalimumab, certolizumab pegol |
Participant Information
| Sponsor | Oslo University Hospital |
|---|---|
| City | Oslo |
| Country/Region | Norway |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2013-05 |
|---|---|
| Primary Completion Date | 2016-05 |
| Completion Date | 2016-11 |